NCT07270406 Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain
| NCT ID | NCT07270406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-16 |
| Primary Completion | 2029-09-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-02-16 with a primary completion date of 2029-09-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to test whether Brief Behavioral Treatment for Insomnia (BBTI) delivered over the phone or Brief Mindfulness Training (BMT) delivered over the phone is better able to improve the symptoms of insomnia, reduce chronic pain, and slow the pace of biological aging in individuals with HIV and Chronic Pain.
Eligibility Criteria
Inclusion Criteria Each subject must meet all of the following criteria and be confirmed with electronic medical records: 1. Confirmed HIV diagnosis and currently a patient in the WashU Infectious Disease Clinic 2. Age 25-65 years 3. All people with HIV must be currently receiving stable antiretroviral therapy 4. People with HIV with insomnia must report Insomnia Severity Index \>/= 15 at initial screening and meet DSM-5 diagnostic criteria for insomnia including sleep difficulty that occurs at least 3 times per week and has been a problem for at least 3 consecutive months 5. People with HIV must also report the presence of chronic pain on the Brief Chronic Pain Screening Questionnaire and rate their chronic pain as \>/= 3 on a 0-10 scale of intensity. Exclusion Criteria Subjects will not be enrolled if any of the following criteria exist and confirmed with electronic medical records: 1. History of stroke in past 12 months 2. Active cancer with treatment 3. Heart disease 4. Uncontrolled hypertension 5. Epilepsy 6. Active pregnancy 7. Reynaud's disease 8. Traumatic injury or surgical procedure within the last 12 months 9. Acute infection as suggested by thermometry temperature \>100.4 10. Serious psychiatric disorder (bipolar disorder, psychotic disorder) 11. Active suicidal ideation 12. Evidence for severe obstructive sleep apnea (AHI \>30/hr) according to Home Sleep Monitoring or presence of another sleep disorder other than insomnia (i.e., not insomnia) as indicated by SCISD-R
Contact & Investigator
Burel Goodin, PhD
PRINCIPAL INVESTIGATOR
WashU Medicine
Frequently Asked Questions
Who can join the NCT07270406 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07270406 currently recruiting?
Yes, NCT07270406 is actively recruiting participants. Contact the research team at dyanw@wustl.edu for enrollment information.
Where is the NCT07270406 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07270406 clinical trial?
NCT07270406 is sponsored by Washington University School of Medicine. The principal investigator is Burel Goodin, PhD at WashU Medicine. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.